Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Stroke prevention devices for TAVR fail to make an impact
Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.
Redo TAVR: Supra-annular, intra-annular valves linked to comparable outcomes
When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival.
Women live longer after TAVR than men
Researchers tracked real-world data from 600 TAVR patients, following each one for approximately five years. Survival rates were similar for men and women early on, but then women started experiencing better outcomes after three years.
FDA warns public about vascular device after 3 deaths
The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.
Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform
Ultreon 3.0 was built to capture and evaluate OCT images, providing real-time guidance during complex PCI procedures.

Stroke prevention devices for TAVR fail to make an impact

Cerebral embolic protection devices are "compelling," researchers wrote, but current data does not suggest they make a significant impact on patient outcomes.

cardiologists evaluating the human heart to provide a treatment strategy

Redo TAVR: Supra-annular, intra-annular valves linked to comparable outcomes

When a TAVR valve fails and that patient undergoes redo TAVR, are there benefits to choosing one device type over the other? The team behind a new study tracked multiple outcomes and identified specific factors that may help predict survival.

Women live longer after TAVR than men

Researchers tracked real-world data from 600 TAVR patients, following each one for approximately five years. Survival rates were similar for men and women early on, but then women started experiencing better outcomes after three years.

FDA warns public about vascular device after 3 deaths

The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.

Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform

Ultreon 3.0 was built to capture and evaluate OCT images, providing real-time guidance during complex PCI procedures.

The Society for Cardiovascular Angiography and Interventions (SCAI) is entering a new chapter as Dawn Abbott, MD, MSCAI, who assumeed the presidency this week with a focus on strengthening the future of interventional cardiology through workforce development, expanded training pathways and continued efforts to broaden inclusion in the specialty. #SCAI2026 #SCAI26

New SCAI President Dawn Abbott outlines workforce training and inclusion priorities

SCAI President Dawn Abbott, MD, MSCAI, aims to turn attention toward the long-term sustainability of the interventional cardiology field.

Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B

Fewer stents, positive outcomes: Sirolimus-eluting balloons a safe alternative during PCI

Using a DCB that releases sirolimus over an extended period of time appears to be both safe and effective when treating patients who present with NSTEMI or unstable angina.

heart data research doctor cardiologist AI

Two separate studies explored the value of treating heart patients with tirzepatide.